| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/11/2013 | CN103285402A New application of polyethylene glycol and pigment epithelium derived growth factor conjugate |
| 09/11/2013 | CN103285363A Drug for treating xerophthalmia with cervical spondylosis |
| 09/11/2013 | CN103285258A Traditional Chinese medicine for treating acute catarrhal otitis media |
| 09/11/2013 | CN103285254A Traditional Chinese medicine for treating otitis and preparation method thereof |
| 09/11/2013 | CN103285118A Snake oil burn cream |
| 09/11/2013 | CN103285080A Plaster and preparation method thereof, and patch and liquid medicine containing plaster |
| 09/11/2013 | CN103285078A Comfortable cream |
| 09/11/2013 | CN103285026A RNAi-mediated inhibition of tumor necrosis factor alpha-related conditions |
| 09/11/2013 | CN103285019A Application of anemonin A in preparing medicine for treating neovascular eye diseases |
| 09/11/2013 | CN103284974A Phencynonate hydrochloride double-layer osmotic pump controlled release tablet and preparation method thereof |
| 09/11/2013 | CN103284961A Preparing method of cobamamide freeze-drying formulation for injection |
| 09/11/2013 | CN102743576B Traditional Chinese medicine preparation for treating tinnitus and deafness |
| 09/11/2013 | CN102671021B Chinese medicament for treating chronic catarrhal otitis media and preparation method |
| 09/11/2013 | CN102670537B Trimetazidine dihydrochloride sustained release tablet and preparation method thereof |
| 09/11/2013 | CN102657665B Compound dehydration and diuresis medicine composition |
| 09/11/2013 | CN102579918B Traditional Chinese medicine composition for treating glaucoma as well as preparation method and administration mode of same |
| 09/11/2013 | CN102370617B Ophthalmic huperzine A microemulsion and preparation method thereof |
| 09/11/2013 | CN102216318B 抗氧化剂 Antioxidants |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8529907 Methods of treating ophthalmic disorders |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529871 in a patient receiving high dose radioactive iodine for treatment of cancer; administering to the eyes of said patient an effective amount of perchlorate anion |
| 09/10/2013 | CA2731769C Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 09/10/2013 | CA2627982C Soft anticholinergic esters |
| 09/10/2013 | CA2608457C Ebselen as a prophylactic or therapeutic agent for corneal or conjunctival disorders |
| 09/10/2013 | CA2451566C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 09/10/2013 | CA2281887C Nucleic acid sequences for atp-binding cassette transporter |
| 09/06/2013 | WO2013130577A2 Compositions and methods for the treatment of migraine |
| 09/06/2013 | WO2013129700A1 Methods and compositions for enhancement of vision performance |
| 09/05/2013 | US20130231297 Dietary supplement for improving visual performance |
| 09/05/2013 | US20130230501 Cycloalkyl-Substituted Imidazole Derivative |
| 09/04/2013 | EP2634176A1 Pyridine derivative and medicinal agent |
| 09/04/2013 | EP2632458A1 Dosing regimes for the treatment of ocular vascular disease |
| 09/04/2013 | EP2632455A1 Ophthalmic compositions |
| 09/04/2013 | EP2632449A1 Treatment of ocular and cerebral ischemia |
| 09/04/2013 | EP2632427A1 Ophthalmic composition |
| 09/04/2013 | CN1578670B Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 09/04/2013 | CN103282053A Medical device for controlled release of drug |
| 09/04/2013 | CN103282052A Aqueous ophthalmic composition |
| 09/04/2013 | CN103282044A Nanoemulsion-type ophthalmic composition |
| 09/04/2013 | CN103282039A Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| 09/04/2013 | CN103276015A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/04/2013 | CN103275984A MCP-1 binding nucleic acids |
| 09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
| 09/04/2013 | CN103275183A VEGFR2 tyrosine kinase inhibitor polypeptide 2 and application thereof |
| 09/04/2013 | CN103274961A Compositions and methods of treating cell proliferation disorders |
| 09/04/2013 | CN103272236A Beta-adrenergic receptor retarder and vitamins B-containing pharmaceutical composition and applications thereof |
| 09/04/2013 | CN103272219A Selective r-cadherin antagonists and methods |
| 09/04/2013 | CN103272135A Composition for relieving asthenopia and preparation method thereof |
| 09/04/2013 | CN103272037A Medicine for curing otitis media and preparation method thereof |
| 09/04/2013 | CN103271991A Peppermint essential oil and mixed cyclodextrin inclusion compound and preparation method thereof |
| 09/04/2013 | CN103271981A Yufengningxin (medicine name) soft capsule and preparation method thereof |
| 09/04/2013 | CN103271934A Sea cucumber extract containing alkaloids active ingredients as well as extracting method and application thereof |
| 09/04/2013 | CN103271897A Applications of mesna in preparation of anti-angiogenesis drugs |
| 09/04/2013 | CN103271896A Preparation method of stable calcium dobesilate |
| 09/04/2013 | CN103271895A Stable calcium dobesilate containing pharmaceutical composition and preparation method thereof |
| 09/04/2013 | CN103271893A Preparation method for lycopene microcapsule |
| 09/04/2013 | CN103271892A Genistein positive ion nano lipid carrier and preparation method thereof |
| 09/04/2013 | CN102727729B Decoction for treating eye disease |
| 09/04/2013 | CN102579844B Medicine for treating Meniere's disease |
| 09/04/2013 | CN102028817B Externally applied drug for preventing and treating myopia and amblyopia and using method of drug |
| 09/04/2013 | CN101505794B scFV antibodies which pass epithelial and/or endothelial layers |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | CA2398277C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 08/29/2013 | WO2013126805A2 Small molecule compounds to treat hearing loss |
| 08/29/2013 | WO2013126799A1 Compositions and methods for ocular delivery of a therapeutic agent |
| 08/29/2013 | WO2013126602A1 Inflammatory eye disorders |
| 08/29/2013 | WO2013126599A1 Meibomian gland dysfunction |
| 08/29/2013 | WO2013126595A1 Methods for treating corneal and conjunctival inflammation and inflammatory disorders |
| 08/29/2013 | WO2013126438A1 Sulfinylbenzyl and thiobenzyl derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/29/2013 | WO2013126428A1 Phenoxy derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/29/2013 | WO2013126381A1 Phenoxy-azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/29/2013 | WO2013126156A1 Nitric oxide donating selective glucocorticoid receptor agonist compounds and ophthalmic compositions |
| 08/29/2013 | WO2013126088A1 Methods of increasing light responsiveness in a subject with retinal degeneration |
| 08/29/2013 | WO2013124484A1 Compositions and methods for the treatment of retinal degeneration |
| 08/29/2013 | WO2013124416A1 Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| 08/29/2013 | WO2013123618A1 Process for manufacture of extract containing zeaxanthin and/or its esters |
| 08/29/2013 | US20130225684 Methods and compositions for enhancement of vision performance |
| 08/28/2013 | EP2629770A1 Method of treating otitis externa using macrocyclic lactone compound |
| 08/28/2013 | CN103270024A Novel substituted isoquinoline derivative |
| 08/28/2013 | CN103269693A Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
| 08/28/2013 | CN103265618A VEGFR(vascular endothelial growth factor)2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/28/2013 | CN103263620A Traditional Chinese medicine preparation for treating sjoegren syndrome and preparation method thereof |
| 08/28/2013 | CN103263468A Traditional Chinese medicine for treating conjunctivitis |
| 08/28/2013 | CN103263417A Itraconazole isomer and medical application thereof |
| 08/28/2013 | CN102250914B Protein for treating ocular vascular proliferation |
| 08/28/2013 | CN102166203B Eye pad for alleviating eye fatigue and preparation method thereof |
| 08/28/2013 | CN101856429B Medicine compound with visual fatigue relieving function and preparation method thereof |
| 08/28/2013 | CN101489575B FKBP-L and uses thereof |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518919 Compositions comprising azelastine and methods of use thereof |
| 08/27/2013 | US8518695 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2584017C Aqueous ophthalmic suspension of crystalline rebamipide |
| 08/27/2013 | CA2505836C Topical brimonidine tartrate formulations that lack chlorine dioxide |
| 08/22/2013 | WO2013122953A1 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators |
| 08/22/2013 | WO2013101911A3 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130216585 Composition and methods for quenching free radicals and modulating inflammation |